[go: up one dir, main page]

CN108101860A - The preparation method of cis -2,6- thebaines - Google Patents

The preparation method of cis -2,6- thebaines Download PDF

Info

Publication number
CN108101860A
CN108101860A CN201810130007.3A CN201810130007A CN108101860A CN 108101860 A CN108101860 A CN 108101860A CN 201810130007 A CN201810130007 A CN 201810130007A CN 108101860 A CN108101860 A CN 108101860A
Authority
CN
China
Prior art keywords
cis
thebaines
preparation
reaction
benzyls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810130007.3A
Other languages
Chinese (zh)
Other versions
CN108101860B (en
Inventor
沈建伟
吴和明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Jingye Medicine & Chemical Co Ltd
Original Assignee
Suzhou Jingye Medicine & Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Jingye Medicine & Chemical Co Ltd filed Critical Suzhou Jingye Medicine & Chemical Co Ltd
Priority to CN201810130007.3A priority Critical patent/CN108101860B/en
Publication of CN108101860A publication Critical patent/CN108101860A/en
Application granted granted Critical
Publication of CN108101860B publication Critical patent/CN108101860B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of preparation methods of cis 2,6 thebaine, which is characterized in that comprises the following steps:(1) using benzylamine and chiral epoxy propane as raw material, through being condensed to yield N benzyl diisopropanolamine (DIPA)s;(2) N benzyls cis 2,6 thebaines are obtained with sulfuric acid dehydration condensation to the N benzyls diisopropanolamine (DIPA) that step (1) obtains;(3) hydrogenation debenzylation is carried out to the product of step (2) and obtains cis 2,6 thebaines.The present invention is using benzylamine and chiral epoxy propane as raw material, and low in raw material price is easy to get, and reaction condition is mild, and reaction yield is high;Cis-isomer content is high in product, fully achieves medicinal requirement.

Description

The preparation method of cis -2,6- thebaines
Technical field
The present invention relates to a kind of synthetic methods of the heterocyclic compound for medicine intermediate, and in particular to it is a kind of it is cis- The preparation method of 2,6- thebaines.
Background technology
Cis -2,6- thebaines are the important intermediates of antitumor drug Sony Ji cloth (Sonidegib).
In the prior art, a kind of method of synthesizing cis -2,6- thebaine is to be deposited with diisopropanolamine (DIPA) in the concentrated sulfuric acid In lower high temperature dehydration cyclization, then high-vacuum fractionation cis-trans isomer [DE2822326 (1979)];Such as formulas below institute Show.
The above method there are the problem of be:The ratio of the cis-isomer of generation is condensed less than 80%(Cis-trans-isomer ratio= 78:22);The purity of the separation product of high-vacuum fractionation is difficult to reach medicinal requirements.
Another method is:Chiral isopropanolamine and the imines Xi Fushi alkali that benzaldehyde generates are also primary with sodium borohydride Into N- benzyls-isopropanolamine;Then become with alpha-brominated propionic acid catalyzing and condensing and cyclization N- benzyl -2,6- dimethyl -3- oxos - Morpholine, last Li-Al hydrogen reduces to obtain and debenzylation obtain cis -2,6- thebaines [JACS, 2009,131,11: 3991~7];
Further, directly it is condensed with chiral isopropanolamine with alpha-chloro propionic acid, the chiral amides of generation are in the presence of butyl alcohol-tert potassium Cyclization obtains 2,6- dimethyl -3- oxo-morpholins;It is finally reduced in tetrahydrofuran solvent with Li-Al hydrogen, obtains cis -2, 6- thebaines [Synthesis (Germany), 2014, vol.46, art. no.46];
This kind of method is reduced using Li-Al hydrogen, and reaction condition is more demanding, and the requirement in production process to security protection is especially high.
Therefore, it is necessary to seek the preparation method of new cis -2,6- thebaines.
The content of the invention
The goal of the invention of the present invention is to provide a kind of preparation method of cis -2,6- thebaines, to improve in product The content of cis-isomer, while make reaction condition mild.
To achieve the above object of the invention, the technical solution adopted by the present invention is:A kind of system of cis -2,6- thebaines Preparation Method comprises the following steps:
(1) using benzylamine and chiral epoxy propane as raw material, through being condensed to yield N- benzyls-diisopropanolamine (DIPA);Reaction equation is as follows:
(2) N- benzyls-cis -2,6- bis- is obtained with sulfuric acid dehydration condensation to N- benzyls-diisopropanolamine (DIPA) that step (1) obtains Methyl morpholine;
(3) hydrogenation debenzylation is carried out to the product of step (2) and obtains cis -2,6- thebaines, reaction equation is as follows:
In above-mentioned technical proposal, in step (1), the chiral epoxy propane is R configurations or S configurations;Benzylamine and chiral epoxy The molar filling ratios of propane are 1: 1.8~2.5;Reaction carried out in polar solvent, reaction temperature for room temperature to 100 DEG C, reaction When time is 1~18 small.
Preferably, the molar filling ratios of benzylamine and chiral epoxy propane are 1: 2.0~2.4;Reaction temperature is 40~80 DEG C, When reaction time is 4~10 small.
It is furthermore preferred that the molar filling ratios of benzylamine and chiral epoxy propane are 1: 2.3~2.4;Reaction temperature is 60~80 DEG C, when the reaction time is 6~8 small.
Wherein, the polar solvent is DMF, DMSO or fatty alcohol.
Preferably, the fatty alcohol is methanol, ethyl alcohol, propyl alcohol, isopropanol, butanol, isobutanol or the tert-butyl alcohol.Optimal selection Methanol, ethyl alcohol or isopropanol.
In step (2), chiral N- benzyls-diisopropanolamine (DIPA) thermal dehydration cyclization in the presence of the concentrated sulfuric acid, chiral N- benzyls- The molar filling ratios of diisopropanolamine (DIPA) and the concentrated sulfuric acid are 1: 1~5, preferably 1: 1.5~2.5, most preferably 1: 1.8~2.0;Reaction temperature Degree control is in room temperature to 230 DEG C, and preferable temperature is 40~180 DEG C, 60~130 DEG C of optimal selection;Reaction time is small for 1~18 When, preferably 3~10 it is small when, most preferably 5~8 it is small when.
From embodiment, the product of step (2) is mainly N- benzyls-cis -2,6- thebaines, cis-trans-isomer Ratio be about 92:2.
In step (3), N- benzyls -2,6- thebaine use catalysis process debenzylation, used catalyst for palladium - Carbon;The weight proportion of substrate and catalyst is 1~10%;Reaction dissolvent is fatty alcohol;Hydrogenation pressure is 1.0~4.5MPa;Reaction Temperature is room temperature to 100 DEG C;When reaction time 1~18 is small.
Preferably, the catalyst is 5~10% palladium-carbon;The weight proportion of substrate and catalyst is 3~8%;The fat Fat alcohol is methanol, ethyl alcohol, propyl alcohol, isopropanol, butanol, isobutanol or the tert-butyl alcohol;Hydrogenation pressure is 1.2~3.0MPa;Reaction temperature It spends for 40~80 DEG C;When reaction time 4~10 is small.
It is furthermore preferred that the catalyst is 5% palladium-carbon;The weight proportion of substrate and catalyst is 4~5%;The fat Alcohol is methanol, ethyl alcohol or isopropanol;Hydrogenation pressure is 1.5~2.0MPa;Reaction temperature is 60~80 DEG C;Reaction time 5~7 is small When.
Since above-mentioned technical proposal is used, the present invention has following advantages compared with prior art:
1st, the present invention is using benzylamine and chiral epoxy propane as raw material, and low in raw material price is easy to get, and reaction condition is mild, reaction yield It is high;
2nd, in product of the invention, cis-isomer content is high, fully achieves medicinal requirement.
Specific embodiment
With reference to embodiment, the invention will be further described:
Embodiment 1:The preparation of chiral N- benzyls-diisopropanolamine (DIPA);
80.2g (0.75mol) benzylamine, 103.0g (1.78mol) are added in 1000ml four-hole bottles(S)- propylene oxide and 600ml Methanol is heated to flowing back, and GC research and applications are reaction end with adduct content≤0.5%, reacts and terminates when about reflux 8 is small, Removed under reduced pressure solvent methanol obtains 168.2g condensation products.Quantitative yield, content more than 97% (GC).
Nuclear magnetic data is as follows, shows to have obtained the product.
1H NMR (CDCl3): δ7.35 ~7.28 (m, 5H;ArH), 3.94 ~ 3.78 (m, 2H;CH2), 3.89 (d, J=13.6 Hz, 1H;), 3.51 N-CH2Ph (d, J=13.6 Hz, 1H;N-CH2Ph), 2.65 (br, 2H; ), 2.45 OH (d, J=6.1 Hz, 4H;), 1.10 N-CH2 (d, J=6.1 Hz, 6H; CH3) ppm。
Embodiment 2, the preparation of N- benzyls-cis -2,6- thebaines
Addition compound product 168.2g is added in 1000ml four-hole bottles(0.75mol), be heated to 60 DEG C, control liquid temperature 100 DEG C with Under, the 133g concentrated sulfuric acids are slowly added dropwise(98% concentration).After completion of dropwise addition, 118 DEG C are heated to, and under the conditions of 118 ~ 122 DEG C Insulation reaction 5 ~ 6hrs, HPLC monitoring, material content≤1.0% are reaction end.After reaction, 70 DEG C are cooled to, control 250ml water is slowly added at 70 DEG C or so.After adding water, 30% liquid caustic soda 400g is added dropwise at 50 DEG C or so for control temperature, adds in 200ml toluene, stirring layering.Water layer is extracted once with 150ml toluene.Merge organic phase, add in 300ml water and a small amount of activated carbon Stirring decoloration 1hr.It filters, the washing of 100ml toluene.Toluene layer uses 300ml water washings once again, and removed under reduced pressure toluene obtains N- benzyls Base-cis -2,6- thebaine 146.0g, yield 95% or so.Content 95% or so(HPLC).
It is as follows to detect nuclear magnetic data:
1H NMR (CDCl3): δ7.32 ~7.21 (m, 5H;ArH), 3.72 ~ 3.63 (m, 2H;2CH), 3.45 (s, 2H;), 2.70 ~ 2.67 CH2 (d, J=15 Hz, 2H; N-CH2), 1.77 ~ 1.70 Ph (dd, J=15 Hz, 2H; N- CH2Ph), 1.13,1.11 (d, J=10 Hz, 6H; CH3) ppm。
Embodiment 3, the preparation of cis -2,6- thebaine hydrochlorides
N- benzyls-cis -2,6- thebaines of 146.0g and 1020ml methanol are put into 2000ml pressure cookers, covers pot Lid, with hydrogen displacement three times.Stirring and heating system are opened, control temperature is at 65 ~ 75 DEG C, and pressure is under the conditions of 1.5 ~ 2.0MPa 5hrs is hydrogenated, until hydrogen is not inhaled substantially(GC monitors reaction end, and reaction solution measures the ratio about 92 of cis-trans-isomer:2). It is cooled to room temperature.Pressure release.It filters, washing, merging filtrate and washing lotion add in 100g concentrated hydrochloric acids(36%), 1hr is stirred into salt.Decompression is de- Except methanol, 250ml toluene is added in, is heated to flowing back, azeotropic dehydration.Then removed under reduced pressure toluene, raffinate cooling and solidifying.In solid 1300ml acetone is added in, is dissolved by heating.Cooling is cooled to less than 5 DEG C, stirs 2hrs.It filters, is washed with 200ml cold acetones.It is dry Obtain solid(White)76.6g.Yield 71% or so.Filtrate and washing lotion merge, and air-distillation removes acetone to 150ml or so.Cooling, It is cooled to less than 5 DEG C, stirs 2hrs.It filters, a small amount of acetone washs to obtain solid, adds in 120ml acetone in solid, dissolves by heating, cold But solid is precipitated.It is cooled to less than 5 DEG C, stirs 2hrs.It filters, the washing of a small amount of acetone, dry solid 8.3g, yield about 7.7%. Merge must cis -2,6- thebaine hydrochloride 84.9g, yield 78.7%.
Embodiment 4, the preparation of cis -2,6- thebaines
Added in 500ml four-hole bottles 84.9g it is cis-liquid caustic soda of 2,6- thebaines hydrochloride and 320g 30%, stirring 1hr.It is layered, the liquid caustic soda of 120g 50% is added in organic layer, stir 1hr, be layered to obtain organic phase.It is evaporated under reduced pressure to product 58.1g. GC measures cis-content 99.41%, transisomer 0.23%.Yield 90% or so.
1HNMR (CDCl3):1.12(D, methyl), 3.57(m,CH),2.496(NH);2.80,2.40(T, CH2).
Merge the lye separated, vacuum distillation, distillate 50g or so.After being dried with lye recyclable 4.0g 99.0% with On product, yield about 6%.

Claims (10)

1. a kind of preparation method of cis -2,6- thebaines, which is characterized in that comprise the following steps:
(1) using benzylamine and chiral epoxy propane as raw material, through being condensed to yield N- benzyls-diisopropanolamine (DIPA);
(2) N- benzyls-cis -2,6- bis- is obtained with sulfuric acid dehydration condensation to N- benzyls-diisopropanolamine (DIPA) that step (1) obtains Methyl morpholine;
(3) hydrogenation debenzylation is carried out to the product of step (2) and obtains cis -2,6- thebaines.
2. the preparation method of cis -2,6- thebaines according to claim 1, it is characterised in that:In step (1), The chiral epoxy propane is R configurations or S configurations;The molar filling ratios of benzylamine and chiral epoxy propane are 1: 1.8~2.5; Reaction carries out in polar solvent, and reaction temperature is room temperature to 100 DEG C, the reaction time for 1~18 it is small when.
3. the preparation method of cis -2,6- thebaines according to claim 2, it is characterised in that:Benzylamine and chirality The molar filling ratios of propylene oxide are 1: 2.0~2.4;Reaction temperature is 40~80 DEG C, when the reaction time is 4~10 small.
4. the preparation method of cis -2,6- thebaines according to claim 3, it is characterised in that:Benzylamine and chirality The molar filling ratios of propylene oxide are 1: 2.3~2.4;Reaction temperature is 60~80 DEG C, when the reaction time is 6~8 small.
5. the preparation method of cis -2,6- thebaines according to claim 2, it is characterised in that:The polarity is molten Agent is DMF, DMSO or fatty alcohol.
6. the preparation method of cis -2,6- thebaines according to claim 5, it is characterised in that:The fatty alcohol It is methanol, ethyl alcohol, propyl alcohol, isopropanol, butanol, isobutanol or the tert-butyl alcohol.
7. the preparation method of cis -2,6- thebaines according to claim 1, it is characterised in that:In step (2), Chiral N- benzyls-diisopropanolamine (DIPA) thermal dehydration cyclization in the presence of the concentrated sulfuric acid, chiral N- benzyls-diisopropanolamine (DIPA) and the concentrated sulfuric acid Molar filling ratios for 1: 1~5, preferably 1: 1.5~2.5, most preferably 1: 1.8~2.0;Reaction temperature is controlled in room temperature to 230 DEG C, preferable temperature is 40~180 DEG C, 60~130 DEG C of optimal selection;Reaction time for 1~18 it is small when, preferably 3~10 it is small when, most It is preferred that 5~8 it is small when.
8. the preparation method of cis -2,6- thebaines according to claim 1, it is characterised in that:In step (3), N- benzyls -2,6- thebaine uses catalysis process debenzylation, and used catalyst is palladium-carbon;Substrate and catalyst Weight proportion is 1~10%;Reaction dissolvent is fatty alcohol;Hydrogenation pressure is 1.0~4.5MPa;Reaction temperature is room temperature to 100 ℃;When reaction time 1~18 is small.
9. the preparation method of cis -2,6- thebaines according to claim 8, it is characterised in that:The catalyst For 5~10% palladium-carbon;The weight proportion of substrate and catalyst is 3~8%;The fatty alcohol is methanol, ethyl alcohol, propyl alcohol, isopropyl Alcohol, butanol, isobutanol or the tert-butyl alcohol;Hydrogenation pressure is 1.2~3.0MPa;Reaction temperature is 40~80 DEG C;Reaction time 4~10 Hour.
10. the preparation method of cis -2,6- thebaines according to claim 9, it is characterised in that:The catalyst For 5% palladium-carbon;The weight proportion of substrate and catalyst is 4~5%;The fatty alcohol is methanol, ethyl alcohol or isopropanol;Hydrogenation Pressure is 1.5~2.0MPa;Reaction temperature is 60~80 DEG C;When reaction time 5~7 is small.
CN201810130007.3A 2018-02-08 2018-02-08 Preparation method of cis-2, 6-dimethyl morpholine Active CN108101860B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810130007.3A CN108101860B (en) 2018-02-08 2018-02-08 Preparation method of cis-2, 6-dimethyl morpholine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810130007.3A CN108101860B (en) 2018-02-08 2018-02-08 Preparation method of cis-2, 6-dimethyl morpholine

Publications (2)

Publication Number Publication Date
CN108101860A true CN108101860A (en) 2018-06-01
CN108101860B CN108101860B (en) 2021-11-23

Family

ID=62220768

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810130007.3A Active CN108101860B (en) 2018-02-08 2018-02-08 Preparation method of cis-2, 6-dimethyl morpholine

Country Status (1)

Country Link
CN (1) CN108101860B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109293649A (en) * 2018-11-12 2019-02-01 新发药业有限公司 A kind of preparation method of Sony's Ji cloth intermediate and Sony's Ji cloth
CN115583923A (en) * 2022-10-19 2023-01-10 枣庄市润安制药新材料有限公司 Preparation method of cis-2,6-dimethylmorpholine

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083202A (en) * 1960-06-06 1963-03-26 Monsanto Chemicals Isomerization of 2, 6-dimethylmorpholine
US4212972A (en) * 1978-07-14 1980-07-15 Basf Aktiengesellschaft Preparation of cis-2,6-dimethylmorpholine
US4298733A (en) * 1979-09-25 1981-11-03 Basf Aktiengesellschaft Preparation of cis-2,6-dimethylmorpholine
EP0129904A2 (en) * 1983-06-25 1985-01-02 BASF Aktiengesellschaft Process for the preparation of cis-2,6-dimethyl morpholine
US4504363A (en) * 1982-05-13 1985-03-12 Basf Aktiengesellschaft Preparation of cis-2,6-dimethylmorpholine
WO2004031195A1 (en) * 2002-10-07 2004-04-15 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
WO2006120563A2 (en) * 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
CN101270098A (en) * 2008-05-08 2008-09-24 上海思协化工科技有限公司 Method for preparing high-purity cis-2,6-dimethyl morpholine
WO2013132380A1 (en) * 2012-03-06 2013-09-12 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
WO2015057659A1 (en) * 2013-10-14 2015-04-23 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
CN105330658A (en) * 2015-12-09 2016-02-17 苏州明锐医药科技有限公司 Preparation method of Sonidegib

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083202A (en) * 1960-06-06 1963-03-26 Monsanto Chemicals Isomerization of 2, 6-dimethylmorpholine
US4212972A (en) * 1978-07-14 1980-07-15 Basf Aktiengesellschaft Preparation of cis-2,6-dimethylmorpholine
US4298733A (en) * 1979-09-25 1981-11-03 Basf Aktiengesellschaft Preparation of cis-2,6-dimethylmorpholine
US4504363A (en) * 1982-05-13 1985-03-12 Basf Aktiengesellschaft Preparation of cis-2,6-dimethylmorpholine
EP0129904A2 (en) * 1983-06-25 1985-01-02 BASF Aktiengesellschaft Process for the preparation of cis-2,6-dimethyl morpholine
WO2004031195A1 (en) * 2002-10-07 2004-04-15 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
WO2006120563A2 (en) * 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
CN101270098A (en) * 2008-05-08 2008-09-24 上海思协化工科技有限公司 Method for preparing high-purity cis-2,6-dimethyl morpholine
WO2013132380A1 (en) * 2012-03-06 2013-09-12 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
WO2015057659A1 (en) * 2013-10-14 2015-04-23 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
CN105330658A (en) * 2015-12-09 2016-02-17 苏州明锐医药科技有限公司 Preparation method of Sonidegib

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HERNESTAM, SVEN: "Reaction of 1,1’-iminobis-2-butanols with sulfuric acid", 《JOURNAL OF HETEROCYCLIC CHEMISTRY》 *
V. A. PAL’CHIKOV 等: "Composition and Reactivity of Aminolysis Products Glycidyl of Phenyl Ether with Benzylamine", 《RUSSIAN JOURNAL OF ORGANIC CHEMISTRY》 *
季世春: "2,6-二甲基吗啉及其衍生物的合成和工艺研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 *
陈朝辉 等: "2,6-二甲基吗啉的制备研究", 《精细化工中间体》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109293649A (en) * 2018-11-12 2019-02-01 新发药业有限公司 A kind of preparation method of Sony's Ji cloth intermediate and Sony's Ji cloth
CN109293649B (en) * 2018-11-12 2020-05-08 新发药业有限公司 Sonchibu intermediate and preparation method of Sonchibu
CN115583923A (en) * 2022-10-19 2023-01-10 枣庄市润安制药新材料有限公司 Preparation method of cis-2,6-dimethylmorpholine
CN115583923B (en) * 2022-10-19 2023-10-17 枣庄市润安制药新材料有限公司 Preparation method of cis-2, 6-dimethyl morpholine

Also Published As

Publication number Publication date
CN108101860B (en) 2021-11-23

Similar Documents

Publication Publication Date Title
Mimura et al. Trifluoroacetaldehyde: a useful industrial bulk material for the synthesis of trifluoromethylated amino compounds
MXPA02007307A (en) Asymmetric synthesis of pregabalin.
CN106432030B (en) A kind of preparation method of Bu Waxitan
CN111592467B (en) Nilaparib intermediate, preparation method and application thereof, and synthetic method of nilapab
KR20100027025A (en) New process for the resolution of enantiomers of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
CN109705011A (en) A kind of synthetic method and intermediate of Upatinib intermediate
CN109232311A (en) A kind of Pregabalin synthetic method of green high-efficient
CN108503564A (en) A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride
WO2001040159A1 (en) New process
CN108101860A (en) The preparation method of cis -2,6- thebaines
US9771317B2 (en) Process for preparing lacosamide and related compounds
TW202321190A (en) Methods for preparing (s)-4-chloro-2-aminobutyric acid hydrochloride and (s)-4-chloro-2-aminobutyrate
CN106008316B (en) A kind of method of synthesis Lei Dipawei chiral intermediates
CN104203915B (en) (3,4 Dichlorobenzene base) ((S) 3 propyl pyrrole alkane 3 base) methanone hvdrochloric acid salt and manufacture method
CN105358529A (en) Novel method for synthesizing key intermediate of apixaban
CN108164423B (en) Preparation method of naftifine hydrochloride
CN113045468A (en) Preparation method of brivaracetam intermediate
CN1972901A (en) Method for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl cyclopropane hydrochloride
CN111943862A (en) Preparation method of heart failure resistant drug Entresto key component Shakuba koji
CN116693437A (en) A kind of synthetic method of N-Boc-3-azetidine acetic acid
WO2021218275A1 (en) Method for synthesizing and refining 4-fluorobenzoylacetonitrile
CN114315609A (en) Process for preparing cis-2-aminocyclohexanol
CN109265385B (en) Synthesis process of chiral catalyst
CN102786489A (en) Preparation method of 5-methyl isoxazole-4-ethyl formate
CN111978242B (en) Preparation method and application of (R) -3-aminopiperidine dihydrochloride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant